Citadel Advisors
INDV icon

Citadel Advisors’s Indivior Pharmaceuticals INDV Stock Holding History

Citadel Advisors’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$109M Buy
3,574,044
+512,142
+17% +$16.9M 0.08% 755
2025
Q4 		$110M Buy
3,061,902
+441,579
+17% +$13.5M 0.07% 794
2025
Q3 		$63.2M Buy
2,620,323
+2,599,177
+12,292% +$54.4M 0.05% 1176
2025
Q2 		$312K Sell
21,146
-48,483
-70% -$565K ﹤0.01% 9728
2025
Q1 		$664K Sell
69,629
-381,167
-85% -$4.01M ﹤0.01% 7840
2024
Q4 		$5.6M Buy
450,796
+138,211
+44% +$1.42M 0.01% 3773
2024
Q3 		$3.05M Buy
312,585
+235,748
+307% +$2.76M ﹤0.01% 4749
2024
Q2 		$1.24M Sell
76,837
-12,558
-14% -$227K ﹤0.01% 6184
2024
Q1 		$1.91M Buy
+89,395
New +$1.68M ﹤0.01% 5610

Other funds holding INDV

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return